Banco Bilbao Vizcaya Argentaria, S.A. Charles River Laboratories International, Inc. Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $9.35 Billion
- Q4 2024
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 2,230 shares of CRL stock, worth $363,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,230
Previous 2,887
22.76%
Holding current value
$363,534
Previous $568,000
27.64%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding CRL
# of Institutions
708Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$829 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$665 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$356 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$295 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.29B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...